En esta página
01LGVN precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
LGVN Clase A Longeveron Inc. - Class A Common stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 12, 2026
$2,58
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$2,30mínimo 52 semanas
$12,30máximo 52 semanas
P/E (TTM)
-2.6
BPA (TTM)
$-1.00
Ingresos (TTM)
$1M
tus insignias
Rango 52S
$2–$12
Calificación del Analista
BUY
Precio Objetivo
$61
P/E
-2.6
ROE
-203.6%
Margen de Beneficio Neto
-1977.6%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
LGVN Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$2.58
P/E (TTM)
-2.6
BPA (TTM)
$-1.00
Ingresos (TTM)
$1M
ROE (TTM)
-203.6%
Rango 52S
$2–$12
LGVN Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 27 de agosto de 2026 | 1-for-10 | Inversa |
| 27 de marzo de 2024 | 1-for-10 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$1M2020-12-31 → 2025-12-31
BPA$-1.292021-12-31 → 2025-12-31
Flujo de caja libre$-19M2021-12-31 → 2025-12-31
Margen neto-1977.6%2021-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | LGVN | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -2.6promedio 5A ≈-34.5 | ≈-34.5 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | LGVN | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Bruto (TTM) | 69.8%promedio 5A ≈57.9% | ≈57.9% | · | · | |
| Margen Operativo (TTM) | -1992.8%promedio 5A ≈-1361.5% | ≈-1361.5% | -2298.3% | En línea | |
| Margen EBITDA (TTM) | -1925.4%promedio 5A ≈-1337.5% | ≈-1337.5% | -2260.7% | En línea | |
| Margen de Beneficio Neto (TTM) | -1977.6%promedio 5A ≈-1352.0% | ≈-1352.0% | -2028.1% | Débil | |
| ROA (TTM) | -145.6%promedio 5A ≈-82.7% | ≈-82.7% | -124.3% | En línea | |
| ROE (TTM) | -203.6%promedio 5A ≈-113.9% | ≈-113.9% | -270.9% | En línea |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | LGVN | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 2.6promedio 5A ≈6.5 | ≈6.5 | 1.8 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 1.2promedio 5A ≈6.0 | ≈6.0 | 1.6 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | LGVN | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -49.9%promedio 5A ≈12.5% | ≈12.5% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -0.63%promedio 5A ≈-9.4% | ≈-9.4% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | -26.6% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | LGVN | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.1promedio 5A ≈0.1 | ≈0.1 | 0.0 | De primer nivel | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 12.8promedio 5A ≈15.4 | ≈15.4 | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$31.6K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-5.9%
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 12, 2026 | $-1.90 | $-1.78 | -6.4% |
| 31 de marzo de 2026 | May 13, 2026 | $-1.90 | $-1.68 | -12.9% |
| 31 de diciembre de 2025 | $-2.30 | $-4.23 | 45.7% | |
| 30 de septiembre de 2025 | $-3.90 | $-2.60 | -49.9% | |
| 30 de junio de 2025 | $-0.33 | $-0.36 | 8.2% | |
| 31 de marzo de 2025 | $-0.34 | $-0.33 | -1.8% | |
| 31 de diciembre de 2024 | $-0.43 | $-0.35 | -24.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $709.0K | $1M | $1M | $6M | |
| Cost of Revenue | $396.0K | $508.0K | $488.0K | $725.0K | $716.0K | $4M | |
| Gross Profit | $803.0K | $2M | $221.0K | $497.0K | $590.0K | $2M | |
| R&D Expense | $12M | $8M | $9M | $9M | $7M | $3M | |
| SG&A Expense | $12M | $10M | $12M | $8M | $10M | $3M | |
| Operating Expenses | $24M | $18M | $21M | $19M | $18M | $6M | |
| Operating Income | $-23M | $-17M | $-21M | $-18M | $-17M | $-4M | |
| Interest Expense | · | · | · | $1M | · | · | |
| Other Non-op | $680.0K | $549.0K | $-377.0K | $300.0K | $411.0K | $57.0K | |
| Income Tax | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-23M | $-16M | $-21M | $-19M | $-17M | $-4M | |
| EPS (Basic) | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 | · | |
| EPS (Diluted) | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 | · | |
| Shares (Basic) | 17,576,551,000 | 9,411,164,000 | 2,173,490,000 | 20,969,032 | 18,915,086 | · | |
| Shares (Diluted) | 17,576,551,000 | 9,411,164,000 | 2,173,490,000 | 20,969,032 | 18,915,086 | · | |
| EBITDA | $-22M | $-16M | · | $-18M | $-17M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $19M | $5M | $11M | $26M | $816.0K | |
| Short-term Investments | · | $0 | $412.0K | $9M | $9M | · | |
| Receivables | $104.0K | $84.0K | $111.0K | $218.0K | $55.0K | · | |
| Prepaid Expense | $686.0K | $308.0K | $376.0K | $404.0K | $282.0K | $52.0K | |
| Current Assets | $5M | $20M | $6M | $20M | $35M | $2M | |
| PP&E (Net) | $2M | $2M | $3M | $3M | $3M | $4M | |
| PP&E (Gross) | $8M | $8M | $7M | $7M | $6M | $6M | |
| Accum. Depreciation | $6M | · | · | · | $3M | $3M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $176.0K | $202.0K | $193.0K | $244.0K | · | · | |
| Total Assets | $10M | $26M | $12M | $27M | $43M | $9M | |
| Accounts Payable | $423.0K | $99.0K | $638.0K | $2M | $645.0K | $2M | |
| Accrued Liabilities | $3M | $2M | $2M | $650.0K | $1M | $2M | |
| Current Liabilities | $4M | $3M | $4M | $5M | $3M | $4M | |
| Capital Leases | $169.0K | $824.0K | $1M | $2M | · | · | |
| Other Non-current Liabilities | $330.0K | $265.0K | $0 | · | · | · | |
| Total Liabilities | $5M | $4M | $5M | $7M | $5M | $7M | |
| Long-term Debt | · | · | · | · | · | $311.0K | |
| Common Stock | · | · | · | $6.0K | $5.0K | · | |
| Paid-in Capital | $138M | $131M | $92M | $84M | $81M | · | |
| Retained Earnings | $-132M | $-110M | $-85M | $-63M | $-44M | · | |
| Treasury Stock | · | · | · | $100.0K | $100.0K | · | |
| AOCI | · | · | $0 | $-357.0K | · | · | |
| Stockholders' Equity | $6M | $22M | $7M | $21M | $37M | $2M | |
| Liabilities + Equity | $10M | $26M | $12M | $27M | $43M | $9M |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $800.0K | $700.0K | $700.0K | $700.0K | $1 | $1 | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $1M | $44.0K | |
| Amort. of Intangibles | $400.0K | $200.0K | $200.0K | $200.0K | $200.0K | $100.0K | |
| Other Non-cash | $2M | $-923.0K | · | $5M | $6M | · | |
| Operating Cash Flow | $-19M | $-14M | $-19M | $-14M | $-10M | $-2M | |
| CapEx | $245.0K | $655.0K | $301.0K | $569.0K | $330.0K | $131.0K | |
| Investing Cash Flow | $-595.0K | $-640.0K | $8M | $-677.0K | $-11M | $-261.0K | |
| Stock Issued | $5M | $13M | $5M | $2.0K | $27M | · | |
| Net Stock Activity | $5M | $13M | · | · | $27M | · | |
| Financing Cash Flow | $5M | $29M | $5M | $-509.0K | $45M | $2M | |
| Taxes Paid | $0 | · | · | · | · | · | |
| Free Cash Flow | $-19M | $-15M | · | $-15M | $-10M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 67.0% | 78.8% | · | 40.7% | 45.2% | · | |
| Operating Margin | -1942.2% | -690.7% | · | -1476.5% | -1336.6% | · | |
| Net Margin | -1893.6% | -667.8% | · | -1541.3% | -1305.1% | · | |
| EBITDA Margin | -1875.5% | -661.4% | · | -1476.5% | -1336.6% | · | |
| ROA | -126.8% | -84.9% | · | -53.7% | -65.5% | · | |
| ROE | -247.7% | -67.2% | · | -83.5% | -57.0% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 7.6 | · | 4.2 | 13.1 | · | |
| Quick Ratio | 1.2 | 7.5 | · | 2.2 | 13.0 | · | |
| Interest Coverage | · | · | · | -12.9 | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.0 | 0.1 | · | |
| Receivables Turnover | 12.8 | 24.5 | · | 9.0 | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.00 | $0.00 | · | $0.06 | · | · | |
| Cash Flow / Share | $-0.00 | $-0.00 | · | $-0.67 | · | · | |
| EPS (TTM) | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -49.9% | 237.4% | -42.0% | -6.4% | -76.8% | · | |
| Revenue CAGR 3Y | -0.63% | 22.4% | -49.9% | · | · | · | |
| Revenue CAGR 5Y | -26.6% | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $2M | $709.0K | $1M | $1M | $6M | |
| Net Income TTM | $-23M | $-16M | $-21M | $-19M | $-17M | $-4M | |
| P/E | -0.4 | -0.7 | -1.3 | -35.8 | -134.1 | · | |
| Earnings Yield | -254.9% | -151.4% | -75.1% | -2.8% | -0.75% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $287.0K | $398.0K | $365.0K | $137.0K | $316.0K | $381.0K | $603.0K | $773.0K | $468.0K | $548.0K | $63.0K | $150.0K | $217.0K | $279.0K | $121.0K | $265.0K | |
| Cost of Revenue | $105.0K | $134.0K | $108.0K | $12.0K | $170.0K | $106.0K | $74.0K | $91.0K | $124.0K | $219.0K | $65.0K | $96.0K | $124.0K | $203.0K | $41.0K | $173.0K | |
| Gross Profit | $182.0K | $264.0K | $257.0K | $125.0K | $146.0K | $275.0K | $529.0K | $682.0K | $344.0K | $329.0K | $-2.0K | $54.0K | $93.0K | $76.0K | $80.0K | $92.0K | |
| R&D Expense | $3M | $2M | $3M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| SG&A Expense | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $4M | $2M | $2M | $2M | |
| Operating Expenses | $6M | $5M | $6M | $7M | $6M | $5M | $5M | $5M | $4M | $4M | $5M | $5M | $6M | $5M | $5M | $5M | |
| Operating Income | $-6M | $-5M | $-5M | $-7M | $-5M | $-5M | $-4M | $-5M | $-4M | $-4M | $-5M | $-5M | $-6M | $-5M | $-5M | $-5M | |
| Other Non-op | $98.0K | $39.0K | $52.0K | $89.0K | $369.0K | $170.0K | $200.0K | $230.0K | $87.0K | $32.0K | $-581.0K | $55.0K | $80.0K | $69.0K | $2M | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-6M | $-5M | $-5M | $-7M | $-5M | $-5M | $-4M | $-4M | $-3M | $-4M | $-6M | $-5M | $-6M | $-5M | $-4M | $-5M | |
| EPS (Basic) | $-0.19 | $-0.19 | $-0.23 | $-0.39 | $-0.33 | $-0.34 | $1.16 | $-0.34 | $-1.83 | $-1.61 | $-2.55 | $-2.79 | $-2.67 | $-2.21 | $-0.21 | $-0.25 | |
| EPS (Diluted) | $-0.19 | $-0.19 | $-0.23 | $-0.39 | $-0.33 | $-0.34 | $1.16 | $-0.34 | $-1.83 | $-1.61 | $-2.55 | $-2.79 | $-2.67 | $-2.21 | $-0.21 | $-0.25 | |
| Shares (Basic) | 31,377,630 | 24,786,282,000 | · | 18,373,198,000 | 15,013,072 | 14,950,734,000 | · | 13,627,793,000 | 6,509,881,000 | 2,513,587,000 | · | 2,117,877,000 | 2,110,544 | 2,103,362 | · | 21,001,613 | |
| Shares (Diluted) | 31,377,630 | 24,786,282,000 | · | 18,373,198,000 | 15,013,072 | 14,950,734,000 | · | 13,627,793,000 | 6,509,881,000 | 2,513,587,000 | · | 2,117,877,000 | 2,110,544 | 2,103,362 | · | 21,001,613 | |
| EBITDA | $-6M | $-5M | · | $-7M | $-5M | $-5M | · | $-5M | $-3M | $-4M | · | $-5M | $-6M | $-5M | · | $-5M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $16M | $5M | $9M | $10M | $14M | $19M | $23M | $12M | $2M | $5M | $2M | $3M | $5M | $11M | $14M | |
| Short-term Investments | · | · | · | · | · | $0 | · | $0 | · | $351.0K | $412.0K | $2M | · | · | $9M | $9M | |
| Receivables | $65.0K | $68.0K | $104.0K | $52.0K | $31.0K | $29.0K | $84.0K | $380.0K | $218.0K | $178.0K | $111.0K | $96.0K | $96.0K | $96.0K | $218.0K | · | |
| Prepaid Expense | $1M | $1M | $686.0K | $1M | $904.0K | $919.0K | $308.0K | $609.0K | $817.0K | $1M | $376.0K | $1M | $2M | $1M | $404.0K | $744.0K | |
| Current Assets | $11M | $17M | $5M | $10M | $11M | $15M | $20M | $24M | $13M | $4M | $6M | $5M | $10M | $15M | $20M | $23M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Accum. Depreciation | $6M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $12.0K | $18.0K | $176.0K | $178.0K | $200.0K | $201.0K | $202.0K | $203.0K | $204.0K | $190.0K | $193.0K | · | · | · | $244.0K | · | |
| Total Assets | $15M | $21M | $10M | $16M | $17M | $21M | $26M | $30M | $19M | $10M | $12M | $12M | $17M | $22M | $27M | $31M | |
| Accounts Payable | $633.0K | $293.0K | $423.0K | $1M | $700.0K | $367.0K | $99.0K | $887.0K | $600.0K | $1M | $638.0K | $829.0K | $2M | · | $2M | $527.0K | |
| Accrued Liabilities | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $613.0K | $650.0K | $728.0K | |
| Current Liabilities | $4M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | $3M | $5M | $4M | $3M | $4M | $4M | $5M | $4M | |
| Capital Leases | $0 | $60.0K | $169.0K | $336.0K | $501.0K | $664.0K | $824.0K | $983.0K | $1M | $1M | $1M | $2M | $2M | · | $2M | · | |
| Other Non-current Liabilities | $0 | $0 | $330.0K | $315.0K | $308.0K | $302.0K | $265.0K | $199.0K | $132.0K | $66.0K | $0 | · | · | · | · | · | |
| Total Liabilities | $5M | $5M | $5M | $6M | $4M | $4M | $4M | $4M | $4M | $7M | $5M | $5M | $6M | $5M | $7M | $6M | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | · | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $153M | $153M | $138M | $137M | $132M | $132M | $131M | $131M | $116M | $92M | $92M | $86M | $85M | $84M | $84M | $83M | |
| Retained Earnings | $-143M | $-137M | $-132M | $-127M | $-120M | $-115M | $-110M | $-106M | $-101M | $-89M | $-85M | $-79M | $-73M | $-67M | $-63M | $-58M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| AOCI | · | · | · | · | · | · | · | $-1.0K | $-1.0K | $1.0K | · | $-309.0K | $-335.0K | $-299.0K | $-357.0K | · | |
| Stockholders' Equity | $10M | $16M | $6M | $10M | $13M | $17M | $22M | $26M | $15M | $3M | $7M | $7M | $11M | $16M | $21M | $25M | |
| Liabilities + Equity | $15M | $21M | $10M | $16M | $17M | $21M | $26M | $30M | $19M | $10M | $12M | $12M | $17M | $22M | $27M | $31M |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $100.0K | $200.0K | $200.0K | $200.0K | $100.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | |
| Stock-based Comp | $373.0K | $379.0K | $376.0K | $448.0K | $513.0K | $340.0K | $390.0K | $1M | $230.0K | $295.0K | $413.0K | $499.0K | $699.0K | $421.0K | $476.0K | · | |
| Amort. of Intangibles | $0 | $100.0K | $0 | $100.0K | $100.0K | $200.0K | $-300.0K | $100.0K | $300.0K | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | $-100.0K | $100.0K | |
| Other Non-cash | · | $-213.0K | · | · | · | $-226.0K | · | · | · | $477.0K | · | · | · | $-1M | · | · | |
| Operating Cash Flow | $-6M | $-4M | $-5M | $-5M | $-4M | $-5M | $-3M | $-3M | $-5M | $-3M | $-4M | $-5M | $-5M | $-6M | $-2M | $-4M | |
| CapEx | $103.0K | $0 | $0 | $57.0K | $161.0K | $27.0K | $13.0K | $430.0K | $196.0K | $16.0K | $164.0K | $3.0K | $92.0K | $42.0K | $66.0K | $378.0K | |
| Investing Cash Flow | $-103.0K | $-20.0K | $-64.0K | $-118.0K | $-263.0K | $-150.0K | $-123.0K | $-478.0K | $-53.0K | $14.0K | $2M | $4M | $2M | $346.0K | $-570.0K | $-2M | |
| Stock Issued | · | · | $836.0K | · | · | · | $0 | $8M | $5M | $100.0K | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $100.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $75.0K | $15M | $777.0K | $4M | $-133.0K | $-58.0K | $-50.0K | $14M | $15M | $63.0K | $5M | $-50.0K | $-86.0K | $-17.0K | $-193.0K | $-27.0K | |
| Free Cash Flow | · | $-4M | · | · | · | $-5M | · | · | · | $-3M | · | · | · | $-6M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 66.3% | · | 91.2% | 46.2% | 72.2% | · | 88.2% | 73.5% | 60.0% | · | 36.0% | 42.9% | 27.2% | · | 34.7% | |
| Operating Margin | -2150.2% | -1199.8% | · | -5335.8% | -1707.9% | -1359.8% | · | -601.4% | -747.9% | -746.4% | · | -3440.7% | -2632.3% | -1690.3% | · | -1957.4% | |
| Net Margin | -2116.0% | -1190.0% | · | -5270.8% | -1591.1% | -1315.2% | · | -571.7% | -729.3% | -740.5% | · | -3404.0% | -2595.4% | -1665.6% | · | -1978.9% | |
| EBITDA Margin | -2080.5% | -1149.5% | · | -5189.8% | -1644.6% | -1307.3% | · | -601.4% | -705.1% | -709.8% | · | -3307.3% | -2540.1% | -1618.6% | · | -1881.9% | |
| ROA | -37.7% | -22.5% | · | -31.8% | -27.8% | -32.8% | · | -21.3% | -18.7% | -25.8% | · | -24.2% | -21.5% | -15.2% | · | -18.2% | |
| ROE | -52.7% | -28.5% | · | -40.6% | -36.5% | -49.6% | · | -27.4% | -26.1% | -41.9% | · | -32.7% | -27.7% | -18.4% | · | -22.3% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 3.9 | · | 2.1 | 3.4 | 5.6 | · | 7.7 | 4.2 | 0.7 | · | 1.5 | 2.5 | 4.1 | · | 6.3 | |
| Quick Ratio | 2.4 | 3.6 | · | 1.9 | 3.2 | 5.3 | · | 7.5 | 3.9 | 0.5 | · | 1.2 | 0.7 | 1.4 | · | 6.0 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 6.0 | 8.2 | · | 0.6 | 2.5 | 3.7 | · | 3.2 | 3.0 | 4.0 | · | 3.1 | 4.5 | 5.8 | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.01 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.07 | $0.22 | · | $0.01 | $0.01 | $0.01 | · | $0.01 | |
| Cash Flow / Share | · | $-0.00 | · | · | · | $-0.00 | · | · | · | $-1.23 | · | · | · | $-0.28 | · | · | |
| EPS (TTM) | $-1.00 | $-1.14 | · | $0.10 | $0.15 | $-1.35 | · | $-6.33 | $-8.78 | $-9.62 | · | $-7.88 | $-5.34 | $-2.94 | · | $-0.89 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $1M | $2M | $2M | · | $2M | $1M | $978.0K | · | $767.0K | $882.0K | $1M | · | $1M | |
| Net Income TTM | $-23M | $-22M | · | $-21M | $-19M | $-17M | · | $-18M | $-19M | $-21M | · | $-20M | $-20M | $-20M | · | $-18M | |
| P/E | -0.7 | -0.9 | · | 7.5 | 8.7 | -1.1 | · | -0.3 | -0.2 | -0.3 | · | -3.0 | -6.3 | -9.1 | · | -41.6 | |
| Earnings Yield | -142.2% | -109.6% | · | 13.3% | 11.5% | -87.1% | · | -326.3% | -545.3% | -296.0% | · | -33.7% | -15.8% | -11.0% | · | -2.4% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $1M | $2M | $709.0K | $1M | $1M |
| Margen Bruto % | 67.0% | 78.8% | · | 40.7% | 45.2% |
| Margen Operativo % | -1942.2% | -690.7% | · | -1476.5% | -1336.6% |
| Beneficio neto | $-23M | $-16M | $-21M | $-19M | $-17M |
| EPS Diluido | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 1.3 | 7.6 | · | 4.2 | 13.1 |
| Ratio Rápido | 1.2 | 7.5 | · | 2.2 | 13.0 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-19M | $-15M | · | $-15M | $-10M |
Propietarios institucionales (13F) 41 declarantes · $3.6M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
41
Valor en tenencia
$3.6M
Nuevas posiciones
13
Posiciones cerradas
5
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 13 (+2 vs trimestre anterior) | 5 (-4 vs trimestre anterior) | 7 (+4 vs trimestre anterior) | 3 (0 vs trimestre anterior) | +2.5M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | $951 778 | 1 353 881 | 26,74% | Acciones |
| Logos Global Management LP | $904 761 | 1 287 000 | 25,42% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $408 657 | 581 305 | 11,48% | Acciones |
| VANGUARD GROUP INC | $252 558 | 499 126 | 7,10% | Acciones |
| BlackRock, Inc. | $157 592 | 224 170 | 4,43% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $143 244 | 203 761 | 4,03% | Acciones |
| JANE STREET GROUP, LLC | $133 831 | 190 370 | 3,76% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $98 509 | 140 127 | 2,77% | Acciones |
| Mariner, LLC | $88 578 | 126 000 | 2,49% | Acciones |
| ADAR1 Capital Management, LLC | $76 209 | 108 406 | 2,14% | Acciones |
| Beacon Pointe Advisors, LLC | $70 300 | 100 000 | 1,98% | Acciones |
| TWO SIGMA SECURITIES, LLC | $39 349 | 55 973 | 1,11% | Acciones |
| STATE STREET CORP | $31 902 | 45 380 | 0,90% | Acciones |
| NORTHERN TRUST CORP | $30 439 | 43 299 | 0,86% | Acciones |
| SCOTIA CAPITAL INC. | $21 090 | 30 000 | 0,59% | Acciones |
| Capital Investment Advisory Services, LLC | $18 647 | 26 525 | 0,52% | Acciones |
| COMMONWEALTH EQUITY SERVICES, LLC | $17 680 | 25 155 | 0,50% | Acciones |
| Hamilton Point Investment Advisors, LLC | $15 780 | 22 446 | 0,44% | Acciones |
| MONETA GROUP INVESTMENT ADVISORS LLC | $14 974 | 21 300 | 0,42% | Acciones |
| XTX Topco Ltd | $14 452 | 20 558 | 0,41% | Acciones |
| ANCHYRA PARTNERS LLC | $14 060 | 20 000 | 0,40% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $13 938 | 19 827 | 0,39% | Acciones |
| Accelerate Investment Advisors LLC | $10 018 | 14 250 | 0,28% | Acciones |
| Valeo Financial Advisors, LLC | $7 640 | 10 867 | 0,21% | Acciones |
| Cambridge Financial Group, LLC | $7 382 | 10 500 | 0,21% | Acciones |
| Tower Research Capital LLC (TRC) | $5 922 | 8 424 | 0,17% | Acciones |
| MCGUIRE CAPITAL ADVISORS INC | $2 812 | 4 000 | 0,08% | Acciones |
| Steward Partners Investment Advisory, LLC | $1 673 | 2 380 | 0,05% | Acciones |
| OSAIC HOLDINGS, INC. | $1 400 | 2 000 | 0,04% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $930 | 1 300 | 0,03% | Acciones |
| Cornerstone Planning Group LLC | $705 | 1 125 | 0,02% | Acciones |
| WELLS FARGO & COMPANY/MN | $703 | 1 000 | 0,02% | Acciones |
| BARCLAYS PLC | $587 | 835 | 0,02% | Acciones |
| MORGAN STANLEY | $478 | 680 | 0,01% | Acciones |
| Allworth Financial LP | $92 | 130 | 0,00% | Acciones |
| Aventura Private Wealth, LLC | $55 | 78 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $42 | 60 | 0,00% | Acciones |
| Virtu Financial LLC | $41 | 58 583 | 0,00% | Acciones |
| UBS Group AG | $4 | 5 | 0,00% | Acciones |
| CWM, LLC | $3 | 3 | 0,00% | Acciones |
| HUNTINGTON NATIONAL BANK | $2 | 1 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Joshua M. Hare, M.D. (2) ×4 presentaciones | 15 de abril de 2024 | · | Presentación inicial | · | SEC |
| DS MED LLC (2), Donald M. Soffer (2) ×2 presentaciones | 25 de mayo de 2022 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 30 insiders · 12 directivos · 18 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Stephen H Willard | Chief Executive Officer | 1 de julio de 2026 F | 771 681 | 0 | 0 | $0 |
| James Nathaniel Powell | Chief Executive Officer | 2 de enero de 2026 F | 125 593 | 0 | 0 | $0 |
| Mohamed Wa'El Ahmed Hashad | Chief Executive Officer | 15 de julio de 2025 A | 420 904 | 0 | 0 | $0 |
| Geoff Green | CEO | 4 de abril de 2022 F | 133 904 | 0 | 0 | $0 |
| Nirav S. Jhaveri | Chief Financial Officer | 17 de agosto de 2026 A | 300 000 | 0 | 0 | $0 |
| Lisa Locklear | Chief Financial Officer | 1 de julio de 2026 F | 443 181 | 0 | 0 | $0 |
| James Clavijo | CFO and Treasurer | 29 de junio de 2023 S | 47 303 | 0 | 0 | $0 |
| Devin Blass | CTO & SVP of CMC | 19 de agosto de 2026 A | 711 735 | 0 | 0 | $0 |
| Nataliya Agafonova | Chief Medical Officer | 19 de agosto de 2026 A | 716 914 | 0 | 0 | $0 |
| Paul T Lehr | General Counsel, Secretary | 19 de agosto de 2026 A | 861 423 | 0 | 0 | $0 |
| Joshua Hare | Chief Scientific Officer | 19 de agosto de 2026 A | 1 607 796 | 0 | 0 | $0 |
| Kwan-Hong Christopher Min | Chief Medical Officer | 4 de abril de 2022 A | 151 978 | 0 | 0 | $0 |
| George A. Paletta Jr. | Consejero | 19 de agosto de 2026 A | 70 000 | 0 | 0 | $0 |
| Roger Joseph Hajjar | Consejero | 19 de agosto de 2026 A | 69 000 | 0 | 0 | $0 |
| Arjun Jj Desai | Consejero | 19 de agosto de 2026 A | 36 000 | 0 | 0 | $0 |
| Ursula Ungaro | Consejero | 19 de agosto de 2026 A | 77 000 | 0 | 0 | $0 |
| Rock Soffer | Consejero | 19 de agosto de 2026 A | 262 034 | 0 | 0 | $0 |
| Deborah Ascheim | Consejero | 19 de agosto de 2026 A | 36 000 | 0 | 0 | $0 |
| Leah Rush Cann | Consejero | 19 de agosto de 2026 A | 36 000 | 0 | 0 | $0 |
| Khoso Baluch | Consejero | 11 de agosto de 2025 P | 52 516 | 0 | 0 | $0 |
| Neha J. Motwani | Consejero | 15 de julio de 2025 A | 33 000 | 0 | 0 | $0 |
| Richard N Kender | Consejero | 15 de julio de 2025 A | 33 000 | 0 | 0 | $0 |
| Neil E Hare | Consejero | 15 de agosto de 2024 A | 29 352 | 0 | 0 | $0 |
| Cathy Ross | Consejero | 10 de enero de 2024 P | 10 000 | 0 | 0 | $0 |
| Jeffrey Pfeffer | Consejero | 28 de diciembre de 2023 P | 15 000 | 0 | 0 | $0 |
| Douglas W Losordo | Consejero | 21 de diciembre de 2023 A | 5 000 | 0 | 0 | $0 |
| Todd C Girolamo | Consejero | 21 de diciembre de 2022 A | 5 000 | 0 | 0 | $0 |
| Donald M Soffer | Consejero | 21 de diciembre de 2022 A | 6 693 737 | 0 | 0 | $0 |
| Erin Borger | Consejero | 21 de diciembre de 2022 A | 0 | 0 | 0 | $0 |
| DS MED LLC | Propietario del 10% | 17 de mayo de 2022 J | 0 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 2 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
LGVN Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 9 analistas
COMPRA
Objetivo mediano
$61.25
+2274,0%
2 22,2%
Compra fuerte
5 55,6%
Compra
2 22,2%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
2 analistas · 2026-10-03Objetivo medio $61.25 +2274,0%
← Por Debajo de Todos los Objetivos
Precio Actual $2.58
Mín$42.50
Media$61.25
Máx$80.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 12, 2026